130 related articles for article (PubMed ID: 38197426)
1. Frail inner limiting membrane maculopathy suggested to describe a new retinal Alport-like condition with two variants in three generations of females.
Petersen SD; Belmouhand M; Hertz JM; Fagerberg C; Brasch-Andersen C; Grauslund J; Munier FL; Larsen M
Ophthalmic Genet; 2024 Jan; ():1-8. PubMed ID: 38197426
[TBL] [Abstract][Full Text] [Related]
2. Ocular features in Alport syndrome: pathogenesis and clinical significance.
Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D
Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157
[TBL] [Abstract][Full Text] [Related]
3. Maculopathy, Fundus Changes and Anterior Lenticonus in Alport Syndrome.
Ratkovic M; Pidro A; Pidro A
Beyoglu Eye J; 2021; 6(1):66-69. PubMed ID: 35005495
[TBL] [Abstract][Full Text] [Related]
4. Bull's eye and pigment maculopathy are further retinal manifestations of an abnormal Bruch's membrane in Alport syndrome.
Savige J; Wang Y; Crawford A; Smith J; Symons A; Mack H; Nicholls K; Wilson D; Colville D
Ophthalmic Genet; 2017; 38(3):238-244. PubMed ID: 27485810
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography angiography findings in patients with Alport syndrome.
Trancoso FG; Gallon L; Bomfim MLA; Silva AFMD; Cade F; Zanetti FR
Arq Bras Oftalmol; 2020; 83(6):473-477. PubMed ID: 33470273
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous Pathogenic
Savige J
Kidney Int Rep; 2022 Sep; 7(9):1933-1938. PubMed ID: 36090501
[TBL] [Abstract][Full Text] [Related]
7. Electroretinographic abnormalities in Alport syndrome with a novel COL4A5 truncated variant (p.Try20GlyfsTer19).
Mizobuchi K; Hayashi T; Ohira R; Nakano T
Doc Ophthalmol; 2023 Jun; 146(3):281-291. PubMed ID: 37162688
[TBL] [Abstract][Full Text] [Related]
8. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
9. A triad of retinal signs in Alport syndrome: The 'stair-case' fovea, choroidal thinning and peripheral schisis.
Ghadiri NJ; Stanojcic N; Raja M; Burton BJ
Eur J Ophthalmol; 2019 Jul; 29(1_suppl):10-14. PubMed ID: 30957516
[TBL] [Abstract][Full Text] [Related]
10. Digenic Alport Syndrome.
Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
[TBL] [Abstract][Full Text] [Related]
11. THE SPECTRUM OF INTERNAL LIMITING MEMBRANE DISEASE IN ALPORT SYNDROME: A Multimodal Imaging Study.
Cicinelli MV; Ritter M; Ghossein C; Aschauer C; Laccone F; Nagel M; Schmidt-Erfurth UM; Jampol LM; Gill MK
Retina; 2022 Feb; 42(2):274-282. PubMed ID: 34483311
[TBL] [Abstract][Full Text] [Related]
12. Alport syndrome. A review of the ocular manifestations.
Colville DJ; Savige J
Ophthalmic Genet; 1997 Dec; 18(4):161-73. PubMed ID: 9457747
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
[TBL] [Abstract][Full Text] [Related]
14. Microstructural and hemodynamic changes in the fundus after pars plana vitrectomy for different vitreoretinal diseases.
Li D; Chen H; Huang S; Jia B; Lu L; Fu J
Graefes Arch Clin Exp Ophthalmol; 2023 Nov; ():. PubMed ID: 37982887
[TBL] [Abstract][Full Text] [Related]
15. Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney disease.
Lin F; Bian F; Zou J; Wu X; Shan J; Lu W; Yao Y; Jiang G; Gale DP
BMC Nephrol; 2014 Nov; 15():175. PubMed ID: 25381091
[TBL] [Abstract][Full Text] [Related]
16. INNER MACULAR CHANGES AFTER VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR RHEGMATOGENOUS RETINAL DETACHMENT: Similarity With Alport Syndrome.
Fukukita H; Ito Y; Iwase T; Kaneko H; Yasuda S; Kataoka K; Terasaki H
Retina; 2019 Dec; 39(12):2332-2340. PubMed ID: 30204731
[TBL] [Abstract][Full Text] [Related]
17. Retinal basement membrane abnormalities and the retinopathy of Alport syndrome.
Savige J; Liu J; DeBuc DC; Handa JT; Hageman GS; Wang YY; Parkin JD; Vote B; Fassett R; Sarks S; Colville D
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1621-7. PubMed ID: 19850830
[TBL] [Abstract][Full Text] [Related]
18. Identification of 27 Novel Variants in Genes
Cerkauskaite A; Savige J; Janonyte K; Jeremiciute I; Miglinas M; Kazenaite E; Laurinavicius A; Strupaite-Sileikiene R; Vainutiene V; Burnyte B; Jankauskiene A; Rolfs A; Bauer P; Schröder S; Cerkauskiene R
Front Med (Lausanne); 2022; 9():859521. PubMed ID: 35419377
[TBL] [Abstract][Full Text] [Related]
19. Ocular Manifestations of Alport Syndrome: Report and Comparison of Two Cases.
Sargazi M; Dehghani S; Dahmardeh M; Mohammadi SO
Cureus; 2023 Oct; 15(10):e47373. PubMed ID: 38022159
[TBL] [Abstract][Full Text] [Related]
20. Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.
Chen Y; Colville D; Ierino F; Symons A; Savige J
Ophthalmic Genet; 2018 Apr; 39(2):208-214. PubMed ID: 29172845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
